Rare kidney & urinary condition
Amyloidosis and the kidney
Amyloidosis deposits misfolded protein fibrils in organs, and the kidney is the most commonly affected - causing heavy protein leak; typing the amyloid correctly is everything, because treatments differ radically.
Key points
The essentials at a glance.
What to look out for, how the diagnosis is confirmed, who looks after it, and the options that exist.
-
01
Kidney amyloidosis usually presents as nephrotic syndrome: heavy proteinuria, swelling and low albumin.
-
02
AL amyloid (from a plasma cell clone) and AA amyloid (from chronic inflammation) are the main kidney types - treatment differs completely.
-
03
Typing uses biopsy with special staining and, in specialist practice, mass spectrometry; the UK National Amyloidosis Centre provides definitive assessment including SAP scanning.
-
04
AL treatment targets the clone with myeloma-type therapy (daratumumab-based regimens); AA treatment controls the inflammatory source.
-
05
Cardiac involvement drives prognosis in AL disease and is always assessed.
Understanding it
What it is, and what happens next.
In plain English - what is going on, how specialists confirm it, and the routes to treatment in the UK.
Amyloid fibrils are proteins that have folded wrongly and stacked into insoluble sheets; the kidney's filters catch them first, leaking protein in quantities that announce the disease. But 'amyloid' is a family name: light chains from a bone marrow clone, inflammation-driven serum amyloid A and several hereditary proteins all produce the same stained biopsy at first glance, while demanding opposite treatments.
UK care runs through the National Amyloidosis Centre in London, where fibril typing, whole-body SAP scintigraphy and organ staging are consolidated; AL disease then moves quickly to clone-directed therapy - where modern regimens achieve deep responses that stabilise or improve kidney function - while AA disease is managed by extinguishing its inflammatory source, from rheumatoid arthritis to periodic fever syndromes.
A quiet reminder
This guide is for information, not medical advice.
Your GP or specialist knows your history and can tell you which parts apply to you. If in doubt, speak to them.
Published 2026-09-27 · Next review 2027-09-27
Frequently asked
Common questions about Amyloidosis and the kidney.
Quick, plain-English answers to what people ask us most.
-
How does amyloidosis affect the kidney?
Amyloidosis affects the kidney when abnormal amyloid proteins build up in kidney tissue, impairing its filtering function and often causing protein to leak into the urine, potentially progressing to kidney failure.
-
What causes amyloid kidney disease?
It results from various underlying forms of amyloidosis, most commonly AL amyloidosis (from abnormal plasma cell proteins) or, in some cases, AA amyloidosis linked to chronic inflammatory conditions, depositing abnormal protein in kidney tissue.
-
What are the symptoms of amyloid kidney disease?
Symptoms include swelling (particularly in the legs and around the eyes) from protein loss in urine, foamy urine, fatigue, and, as the condition progresses, symptoms of declining kidney function.
-
Is amyloid kidney disease dangerous?
Yes, it can progress to significant kidney impairment and eventually kidney failure requiring dialysis or transplant if the underlying amyloidosis isn't identified and treated.
-
Can amyloid kidney disease be treated?
Yes, treating the underlying cause of amyloidosis, particularly with chemotherapy-based treatment for AL amyloidosis, can stabilise or sometimes improve kidney function, especially if started before significant kidney damage has occurred.
-
How is amyloid kidney disease treated?
Treatment focuses on the underlying amyloidosis type, often involving chemotherapy-based regimens for AL amyloidosis, alongside supportive kidney care and, if kidney failure develops, dialysis or transplant.
-
How is amyloid kidney disease diagnosed?
Diagnosis typically requires a kidney biopsy showing characteristic amyloid deposits, along with blood and urine tests to identify the underlying type and cause of amyloidosis.
-
Amyloid kidney disease vs typical chronic kidney disease — what's the difference?
Typical chronic kidney disease often results from conditions like diabetes or high blood pressure causing gradual damage, while amyloid kidney disease results from a specific abnormal protein deposition process, confirmed by biopsy, requiring treatment directed at the underlying amyloidosis rather than standard kidney disease management alone.
-
Can kidney function recover after amyloidosis treatment?
In some cases, particularly with early treatment before significant kidney damage, function can stabilise or improve; however, established significant damage often doesn't fully reverse, making early diagnosis important.
-
When should I see a doctor about possible amyloid kidney disease, and how quickly can I be seen privately?
See a doctor for unexplained swelling with foamy urine or declining kidney function. NHS nephrology referral can take several weeks, while private specialist assessment is often available within about two weeks.